A novel biomarker of amnestic MCI based on dynamic cross-frequency coupling patterns during cognitive brain responses

Stavros I. Dimitriadis, Nikolaos Laskaris, Malamati Bitzidou, Ioannis Tarnanas, Magda TsolakiFrontiers in Neuroscience 2015 · DOI

Abstract

The detection of mild cognitive impairment (MCI), the transitional stage between normal cognitive changes of aging and the cognitive decline caused by AD, is of paramount clinical importance, since MCI patients are at increased risk of progressing into AD. Electroencephalographic (EEG) alterations in the spectral content of brainwaves and connectivity at resting state have been associated with early-stage AD. Recently, cognitive event-related potentials (ERPs) have entered into the picture as an easy to perform screening test. Motivated by the recent findings about the role of cross-frequency coupling (CFC) in cognition, we introduce a relevant methodological approach for detecting MCI based on cognitive responses from a standard auditory oddball paradigm. By using the single trial signals recorded at Pz sensor and comparing the responses to target and non-target stimuli, we first demonstrate that increased CFC is associated with the cognitive task. Then, considering the dynamic character of CFC, we identify instances during which the coupling between particular pairs of brainwave frequencies carries sufficient information for discriminating between normal subjects and patients with MCI. In this way, we form a multiparametric signature of impaired cognition. The new composite biomarker was tested using data from a cohort that consists of 25 amnestic MCI patients and 15 age-matched controls. Standard machine-learning algorithms were employed so as to implement the binary classification task. Based on leave-one-out cross-validation, the measured classification rate was found reaching very high levels (95%). Our approach compares favorably with the traditional alternative of using the morphology of averaged ERP response to make the diagnosis and the usage of features from spectro-temporal analysis of single-trial responses. This further indicates that task-related CFC measurements can provide invaluable analytics in AD diagnosis and prognosis.

Introduction

Alzheimer’s Disease (AD) remains a significant challenge in neurodegenerative medicine, often diagnosed only after substantial brain damage has occurred. Identifying Mild Cognitive Impairment (MCI)—specifically the amnestic subtype (aMCI)—is critical for early intervention. While high-cost imaging like MRI and PET scans are standard, there is an urgent need for low-cost, accessible diagnostic tools.

Traditional Electroencephalography (EEG) analysis has focused on "Event-Related Potentials" (ERPs), which average the brain's electrical response to stimuli. However, these morphological markers often lack the sensitivity required to distinguish early-stage aMCI from healthy aging. This research proposes a shift toward analyzing the "neural syntax" of the brain: cross-frequency coupling (CFC). By examining how different frequency bands interact—such as a slow rhythm modulating the amplitude of a faster one—we can detect functional impairments that static snapshots miss.

Methodology

The study utilized a standard auditory oddball paradigm, requiring 40 participants (25 aMCI patients and 15 healthy controls) to count rare "target" tones amidst frequent "non-target" tones. The core innovation is the Time-Varying Phase-Amplitude Coupling (TVPAC) estimator.

Extraction of low-frequency phase information from EEG signals.

The methodology involves filtering EEG signals into seven frequency bands. As shown in the figures, the process extracts the phase of low-frequency oscillations (e.g., theta) and the amplitude envelope of high-frequency oscillations (e.g., beta or gamma).

High-frequency amplitude envelope used for coupling analysis.

By tracking how these components interact millisecond-by-millisecond, the researchers identified specific "latencies-of-interest" where coupling patterns differed most between groups. These dynamic patterns were then used to train a Linear Support Vector Machine (SVM) to create a multiparametric diagnostic signature.

Key Results

The TVPAC-based biomarker demonstrated exceptional diagnostic power, significantly outperforming traditional methods:

  • Classification Accuracy: The model achieved a 95% accuracy rate using cross-validation.
  • Sensitivity: In several models, sensitivity reached 100%, successfully identifying every aMCI case in the cohort.
  • Benchmark Comparison: Traditional Time-Locked Averaging (TLA) achieved only 70% accuracy, while Spectro-Temporal features (STFT) reached 62.5%.

These results suggest that the timing and interaction of brain frequencies are far more predictive of cognitive health than the simple voltage or shape of the ERP waves.

Discussion and Conclusion

A notable finding was the presence of "hyper-synchronization" in aMCI patients. Specifically, increased coupling in $\theta \rightarrow \beta_1$ and $\beta_2 \rightarrow \gamma$ pairs was observed. This is interpreted as a compensatory mechanism where the impaired brain recruits more resources and increases synchronization to perform simple cognitive tasks.

While the current sample size is modest, the high accuracy and sensitivity of the TVPAC approach highlight the potential of task-related CFC as a robust, non-invasive biomarker for AD prognosis. Future longitudinal studies will be essential to determine if these specific coupling signatures can predict the rate of progression from MCI to clinical Alzheimer's Disease.

Summary updated

Abstract

The detection of mild cognitive impairment (MCI), the transitional stage between normal cognitive changes of aging and the cognitive decline caused by AD, is of paramount clinical importance, since MCI patients are at increased risk of progressing into AD. Electroencephalographic (EEG) alterations in the spectral content of brainwaves and connectivity at resting state have been associated with early-stage AD. Recently, cognitive event-related potentials (ERPs) have entered into the picture as an easy to perform screening test. Motivated by the recent findings about the role of cross-frequency coupling (CFC) in cognition, we introduce a relevant methodological approach for detecting MCI based on cognitive responses from a standard auditory oddball paradigm. By using the single trial signals recorded at Pz sensor and comparing the responses to target and non-target stimuli, we first demonstrate that increased CFC is associated with the cognitive task. Then, considering the dynamic character of CFC, we identify instances during which the coupling between particular pairs of brainwave frequencies carries sufficient information for discriminating between normal subjects and patients with MCI. In this way, we form a multiparametric signature of impaired cognition. The new composite biomarker was tested using data from a cohort that consists of 25 amnestic MCI patients and 15 age-matched controls. Standard machine-learning algorithms were employed so as to implement the binary classification task. Based on leave-one-out cross-validation, the measured classification rate was found reaching very high levels (95%). Our approach compares favorably with the traditional alternative of using the morphology of averaged ERP response to make the diagnosis and the usage of features from spectro-temporal analysis of single-trial responses. This further indicates that task-related CFC measurements can provide invaluable analytics in AD diagnosis and prognosis.
BibTeX
@inproceedings{dimitriadis2015novel,
  author = {Stavros I. Dimitriadis and Nikolaos Laskaris and Malamati Bitzidou and Ioannis Tarnanas and Magda Tsolaki},
  title = {{A novel biomarker of amnestic MCI based on dynamic cross-frequency coupling patterns during cognitive brain responses}},
  booktitle = {Frontiers in Neuroscience},
  year = {2015},
  doi = {10.3389/fnins.2015.00350},
}
Figure